Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
PENTWATER EQUITY OPPORTUNITIES MASTER FUND LTD. et al v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al
Case Number:
3:17-cv-07552
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
September 17, 2018
Valeant Must Face Deceptive Pricing Claims By Hedge Funds
A New Jersey federal judge has refused to toss claims in a hedge fund group's lawsuit accusing Valeant Pharmaceuticals International Inc. of duping investors about the sustainability of its business model, ruling on Friday that the claim wasn't filed too late under federal securities law.
-
September 28, 2017
Valeant Used 'Clandestine Network' To Cook Books, Says Suit
Valeant Pharmaceuticals International Inc. misrepresented to investors that its growth was driven by acquisitions rather than by deceptive sales practices, ultimately causing shares to plunge more than 90 percent, shareholders claimed Wednesday in New Jersey federal court.